| Advances in nanocarrier-mediated delivery of chrysin: Enhancing solubility, bioavailability, and anticancer efficacy S Dabiri, S Jafari, O Molavi | | 2025 |
| Epstein-Barr virus-encoded BART9 and BART15 miRNAs are elevated in exosomes of cerebrospinal fluid from relapsing-remitting multiple sclerosis patients M Mohammadinasr, S Montazersaheb, V Hosseini, H Kahroba, M Talebi, ... Cytokine 179, 156624, 2024 | 1 | 2024 |
| Nano-delivery of Silibinin Potentiate the Induction of Immunogenic Cell Death (ICD) in Melanoma Cells. M Amiri, S Jafari, A Lavasanifar, O Molavi, S Montazersaheb Current Pharmaceutical Biotechnology, 2024 | 1 | 2024 |
| Exosome content–mediated signaling pathways in multiple sclerosis M Mohammadinasr, S Montazersaheb, H Ayromlou, V Hosseini, O Molavi, ... Molecular Neurobiology, 1-14, 2024 | 5 | 2024 |
| Annexin A1, Calreticulin and High Mobility Group Box 1 are elevated in Secondary Progressive Multiple Sclerosis: Does Immunogenic Cell Death Occur in Multiple Sclerosis? MS Hejazi, S Jafari, S Montazersaheb, O Molavi, V Hoseini, M Talebi, ... bioRxiv, 2024.01. 12.575470, 2024 | | 2024 |
| A Review of the in Silico Design and Development Approaches of Ras-Specific Anticancer Therapeutics P Motiei, HR Heidari, MS Hejazi, O Molavi, E Mehdizadeh Aghdam International Journal of Peptide Research and Therapeutics 30 (1), 2, 2023 | | 2023 |
| Oxidative stress regulation and related metabolic pathways in epithelial–mesenchymal transition of breast cancer stem cells R Farahzadi, B Valipour, E Fathi, S Pirmoradi, O Molavi, S Montazersaheb, ... Stem Cell Research & Therapy 14 (1), 342, 2023 | 6 | 2023 |
| Stimulators of immunogenic cell death for cancer therapy: focusing on natural compounds M Amiri, O Molavi, S Sabetkam, S Jafari, S Montazersaheb Cancer Cell International 23 (1), 200, 2023 | 7 | 2023 |
| Multiplex analysis of cerebrospinal fluid and serum exosomes MicroRNAs of untreated relapsing remitting multiple sclerosis (RRMS) and proposing noninvasive diagnostic biomarkers M Mohammadinasr, S Montazersaheb, O Molavi, H Kahroba, M Talebi, ... NeuroMolecular Medicine 25 (3), 402-414, 2023 | 8 | 2023 |
| Chrysin and chrysin-loaded nanocarriers induced immunogenic cell death on B16 melanoma cells Y Oliyapour, S Dabiri, O Molavi, MS Hejazi, S Davaran, S Jafari, ... Medical Oncology 40 (10), 278, 2023 | 3 | 2023 |
| The Importance of Qualitative/Quantitative Analytical Tools in COVID-19 Vaccine Development B Seyfinejad, O Molavi, A Jouyban ImmunoAnalysis 3 (1), 8-8, 2023 | | 2023 |
| Synergistic Cytotoxic Effect of Imiquimod and Cisplatin Combination Therapy on A549 Lung Cancer Cell L Rostamizadeh, B Baradaran, K Rostamizadeh, O Molavi, S Safaee, ... ImmunoAnalysis 3, 5, 2023 | | 2023 |
| Clinical significance of carnitine in the treatment of cancer: from traffic to the regulation R Farahzadi, MS Hejazi, O Molavi, E Pishgahzadeh, S Montazersaheb, ... Oxidative Medicine and Cellular Longevity 2023 (1), 9328344, 2023 | 3 | 2023 |
| Silibinin induces immunogenic cell death in cancer cells and enhances the induced immunogenicity by chemotherapy S Jafari, S Heydarian, R Lai, EM Aghdam, O Molavi BioImpacts: BI 13 (1), 51, 2023 | 13 | 2023 |
| Silibinin-loaded nanostructured lipid carriers for growth inhibition of cisplatin-resistant ovarian Cancer cells S Jafari, A Bakhshaei, M Eskandani, O Molavi ASSAY and Drug Development Technologies 20 (8), 339-348, 2022 | 2 | 2022 |
| Copper (II) complexes based bis (pyrazolyl) borate derivatives as efficient anticancer agents: synthesis, characterization, X-ray structure, cytotoxicity, molecular docking and … M Ghorbanpour, B Soltani, O Molavi, A Shayanfar, ... Chemical Papers 76 (12), 7343-7356, 2022 | 4 | 2022 |
| Copper (II) complexes with N, S donor pyrazole-based ligands as anticancer agents M Ghorbanpour, B Soltani, A Mota, J Jahanbin Sardroodi, ... Biometals 35 (5), 1095-1111, 2022 | 9 | 2022 |
| Modulation of Tumor Microenvironment by Targeting HIF-1α, Enhances the Therapeutic Efficacy of Chemoimmunotherapy in Mice Model of Colon Cancer L Rostamizadeh, M Ramezani, H Monirinasab, K Rostami Zadeh, ... Enhances the Therapeutic Efficacy of Chemoimmunotherapy in Mice Model of …, 2022 | | 2022 |
| The Fractions of Eryngium thyrsoideum Extract Sensitize Breast Cancer Cells to Apoptosis K Hosseini, MP Ariya, O Molavi, P Asgharian, V Tarhriz Jundishapur Journal of Natural Pharmaceutical Products 17 (3), 2022 | 1 | 2022 |
| Eryngium billardieri extract and fractions induce apoptosis in cancerous cells S Hasanbeiglu, K Hosseini, O Molavi, P Asgharian, V Tarhriz Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2022 | 6 | 2022 |
Afsaneh LavasanifarProfessor, University of Alberta在 ualberta.ca 的电子邮件经过验证
